Rapport Therapeutics Funding Round

8/23/2023

Venture Equity

$150,000,000

Series B

The company intends to use the funds to support ongoing clinical programs in seizure and psychiatric disorders and precision neuromedicine discovery platform.

Private & Independent

Biopharmaceutical

201 Brookline Ave 1401
Boston, MA 02215
USA

As a word, Rapport describes relationships characterized by understanding, communication, teamwork, and trust. We reflect those qualities in our daily work, where we operate as one committed team that captures the collective knowledge and experience of all our members to maximally improve patients' lives. And at a higher level we share an ambition and a passion to create impactful neuromedicines, with fewer side effects, that allow patients and their families to live healthier and more fulfilling lives. On a molecular scale, our deep understanding of the intricate relationships between receptors, their associated proteins, and their distributions in specific cell types and brain regions enables us to precisely direct medicines to the neural circuits underlying disease pathophysiology.